Triangle Pharma

Acquired

Home - Alcami

Durham, United States · Founded 1995

Founded
1995
Business Model
B2B
Last Round
Venture Round
Rounds
1
Acquired by
GileadDec 2002

About

Triangle Pharmaceuticals, Inc. was a specialty pharmaceutical company engaged in developing new antiviral drug candidates, with a particular focus on therapies for HIV and hepatitis B. Its proprietary pipeline included Coviracil (emtricitabine), amdoxovir, and clevudine. Headquartered in Durham, North Carolina, the company was acquired by Gilead Sciences in a $464 million transaction announced in December 2002, strengthening Gilead's antiviral franchise.

Summary

Triangle Pharma is a Biotech company based in Durham, United States, founded in 1995. Investors include Domain Associates, SV Health Investors and Venrock.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

AcquisitionDec 2002

Sign up to see all 2 rounds

Venture Round through Acquisition — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Triangle Pharma on Indexed.vc
<a href="https://indexed.vc/companies/triangle-pharma"><img src="https://indexed.vc/api/badge/company/triangle-pharma" alt="Triangle Pharma on Indexed.vc" width="260" height="76" /></a>